Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 women found that those taking GLP-1 drugs, a category that includes semaglutide-based medications like Ozempic and Wegovy, were significantly less likely to develop breast cancer.

1. Homepage
2. Science
3. Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk